| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |